MetaVia (NASDAQ:MTVA) reported quarterly losses of $(0.90) per share which missed the analyst consen

HC Wainwright & Co. analyst Andrew S. Fein reiterates MetaVia (NASDAQ:MTVA) with a Buy and ma

All Active Patients in Both Cohorts Have Successfully Reached Highest Target Doses of 48 mg and 64 m

GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT

DA-1726 Phase 1, 48 mg Cohort Achieved Up to 9.1% Mean Body Weight Reduction at Day 54 Without Evide

Solidion Technology, Inc. (NASDAQ: STI) rose 50.55% in pre-market trading on Friday after announcing

MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company focused on transforming cardiomet

48 mg Cohort Achieved Up to 9.1% Mean Body Weight Reduction at Day 54 Without Evidence of PlateauExp

Discover why MetaVia Inc. (NASDAQ: MTVA) stock is surging on Friday following new peer-reviewed data

MetaVia Inc. (NASDAQ: MTVA) shares drop over 10% on Thursday due to profit-taking despite announcing

The paper, entitled, "A Novel Anti-Fibrotic Role of G-Protein-Coupled Receptor 119 in Hepatic St

Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial

HC Wainwright & Co. analyst Andrew S. Fein reiterates MetaVia (NASDAQ:MTVA) with a Buy and ma

MetaVia (NASDAQ:MTVA) reported quarterly losses of $(0.79) per share which missed the analyst consen

MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company focused on transforming cardiomet

16-Week Study Evaluates One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obe

HC Wainwright & Co. analyst Andrew S. Fein maintains MetaVia (NASDAQ:MTVA) with a Buy and low

MetaVia (NASDAQ:MTVA) reported quarterly losses of $(0.42) per share which beat the analyst consensu

Patent Portfolio Includes 48 Granted and Pending Patents in the U.S., Europe, Japan, China and other

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiome